ArticleJournal of clinical and experimental dentistry2025
Management of oral lesions in toxic epidermal necrolysis with photobiomodulation: Report of three cases.
Article in Journal of clinical and experimental dentistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Toxic epidermal necrolysis (TEN) is a mucocutaneous hypersensitivity reaction to certain drugs and/or infections that can lead to multisystem involvement. The oral cavity is affected in almost all cases. The aim of this study was to report three clinical cases of TEN managed with photobiomodulation therapy (PBMT) and antimicrobial photodynamic therapy (aPDT) for the treatment of oral lesions. All patients presented with oral ulcers at various locations. Treatment consisted of oral hygiene with 0.12% chlorhexidine digluconate combined with PBMT applied to strategic sites and aPDT applied to areas of secondary infection. The proposed therapeutic approach resulted in significant clinical improvement of the oral lesions, even prior to improvement of skin manifestations, including pain relief and accelerated tissue healing. These findings suggest that PBMT and aPDT may be effective in improving the oral condition of patients with TEN.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.